Carta Acesso aberto Revisado por pares

Hospitalisation associated with SARS-CoV-2 delta variant in Denmark

2021; Elsevier BV; Volume: 21; Issue: 10 Linguagem: Inglês

10.1016/s1473-3099(21)00580-6

ISSN

1474-4457

Autores

Peter Bager, Jan Wohlfahrt, Morten Rasmussen, Mads Albertsen, Tyra Grove Krause,

Tópico(s)

COVID-19 diagnosis using AI

Resumo

The SARS-CoV-2 B.1.617.2 (delta) variant was first reported in India in December, 2020, and by July, 2021, was predominant over the B.1.1.7 (alpha) variant in most of Europe due to its higher transmissibility.1Singh J Rahman SA Ehtesham NZ Hira S Hasnain SE SARS-CoV-2 variants of concern are emerging in India.Nat Med. 2021; 27: 1131-1133Crossref PubMed Scopus (255) Google Scholar, 2Twohig KA Nyberg T Zaidi A et al.Hospital admission and emergency care attendance risk for SARS-CoV-2 delta (B.1.617.2) compared with alpha (B.1.1.7) variants of concern: a cohort study.Lancet Infect Dis. 2021; (published online Aug 27.)https://doi.org/10.1016/S1473-3099(21)00475-8Summary Full Text Full Text PDF PubMed Scopus (494) Google Scholar Infections with the alpha variant have been shown to be more severe than preceding SARS-CoV-2 strains,3Nyberg T Twohig KA Harris RJ et al.Risk of hospital admission for patients with SARS-CoV-2 variant B.1.1.7: cohort analysis.BMJ. 2021; 373n1412Crossref PubMed Scopus (90) Google Scholar, 4Bager P Wohlfahrt J Fonager J et al.Risk of hospitalisation associated with infection with SARS-CoV-2 lineage B.1.1.7 in Denmark: an observational cohort study.Lancet Infect Dis. 2021; (published online June 22.)https://doi.org/10.1016/S1473-3099(21)00290-5Summary Full Text Full Text PDF PubMed Scopus (79) Google Scholar and a similar concern has now been raised for infections with the delta variant, particularly among unvaccinated people, although vaccination is effective against COVID-19 hospitalisation. Katherine Twohig and colleagues2Twohig KA Nyberg T Zaidi A et al.Hospital admission and emergency care attendance risk for SARS-CoV-2 delta (B.1.617.2) compared with alpha (B.1.1.7) variants of concern: a cohort study.Lancet Infect Dis. 2021; (published online Aug 27.)https://doi.org/10.1016/S1473-3099(21)00475-8Summary Full Text Full Text PDF PubMed Scopus (494) Google Scholar reported an increased hospitalisation risk for delta variant infections (hazard ratio 2·26 [95% CI 1·32–3·89]) compared with alpha variant infections in England between March 29 and May 23, 2021. The study included 196 patients admitted to hospital with the delta variant, 47 (24%) of whom were admitted more than 21 days after first vaccination. To corroborate these results, we updated our Danish national analysis of hospitalisation risk associated with the alpha variant between Jan 1 and March 28, 2021,4Bager P Wohlfahrt J Fonager J et al.Risk of hospitalisation associated with infection with SARS-CoV-2 lineage B.1.1.7 in Denmark: an observational cohort study.Lancet Infect Dis. 2021; (published online June 22.)https://doi.org/10.1016/S1473-3099(21)00290-5Summary Full Text Full Text PDF PubMed Scopus (79) Google Scholar with cases until June 27, 2021, including patients with the delta lineage. We found a similarly increased risk of hospitalisation associated with the delta variant (risk ratio 2·83 [95% CI 2·02–3·98]; appendix p 2). Our analysis included 44 patients admitted to hospital with the delta variant, only four (9%) of whom were admitted more than 14 days after first vaccination. The risk of hospitalisation was only significantly increased among non-vaccinated people and among those who tested positive within 14 days after the first vaccine dose (appendix p 2). We consider the two study findings comparable (because the underlying populations had similar COVID-19 vaccine coverage and rollout for doses one and two, and despite the Oxford-AstraZeneca ChAdOx1 vaccine comprising approximately 3% of administered vaccine doses by June 23, 2021, in Denmark, which is lower than in England). In addition, there were only minor differences between the analyses in regression method and adjustment factors. The observed hospitalisation risk for delta variant infections might, as Twohig and colleagues2Twohig KA Nyberg T Zaidi A et al.Hospital admission and emergency care attendance risk for SARS-CoV-2 delta (B.1.617.2) compared with alpha (B.1.1.7) variants of concern: a cohort study.Lancet Infect Dis. 2021; (published online Aug 27.)https://doi.org/10.1016/S1473-3099(21)00475-8Summary Full Text Full Text PDF PubMed Scopus (494) Google Scholar suggest, be key for resource planning to mitigate the impact of the delta variant in countries with rapid spread, despite vaccination. However, it could be argued that it is increasingly difficult to determine causality of the relative severity across emerging variants using surveillance data as the pandemic is constantly changing with respect to testing patterns, age distribution, and social behaviour with the rollout of the vaccination programme. In addition, the vaccine effectiveness against infection and hospitalisations might also vary depending on circulating variants.5Cevik M Mishra S SARS-CoV-2 variants and considerations of inferring causality on disease severity.Lancet Infect Dis. 2021; (published online June 22.)https://doi.org/10.1016/S1473-3099(21)00338-8Summary Full Text Full Text PDF Scopus (16) Google Scholar We declare no competing interests. The datasets analysed during the current study are located in the Danish national COVID-19 surveillance system database at Statens Serum Institut, and the data are becoming or are already available for research upon request and with permission from the Danish Data Protection Agency and Danish Health Authority (https://sundhedsdatastyrelsen.dk/da/forskerservice). Download .pdf (.14 MB) Help with pdf files Supplementary appendix Hospital admission and emergency care attendance risk for SARS-CoV-2 delta (B.1.617.2) compared with alpha (B.1.1.7) variants of concern: a cohort studyThis large national study found a higher hospital admission or emergency care attendance risk for patients with COVID-19 infected with the delta variant compared with the alpha variant. Results suggest that outbreaks of the delta variant in unvaccinated populations might lead to a greater burden on health-care services than the alpha variant. Full-Text PDF Open Access

Referência(s)